Maxadilan prevents apoptosis in iPS cells and shows no effects on the pluripotent state or karyotype

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Zhao, Zhiyi ^a,b,c   Yu, Rongjie ^c   Yang, Jiayin ^d   Liu, Xiaofei ^c   Tan, Meihua ^a,b,c   Li, HongYang ^a,b,c   Chen, Jiansu ^a,b,c  

^a THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; LIPOCORTIN 5; MAXADILAN; MESSENGER RNA; PROPIDIUM IODIDE; INSECT PROTEIN; MAXADILAN PROTEIN, LUTZOMYIA LONGIPALPIS; PRIMER DNA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; KARYOTYPE; KARYOTYPING; NICK END LABELING; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET C RADIATION; WESTERN BLOTTING; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; PHYSIOLOGY;

IPS;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU NICK-END LABELING; INSECT PROTEINS; KARYOTYPING; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863338664     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033953     Document Type: Article

References (31)

1. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
2. Kao CL, Tai LK, Chiou SH, Chen YJ, Lee KH, et al. (2010) Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 19: 247-258.
3. Olmer R, Haase A, Merkert S, Cui W, Palecek J, et al. (2010) Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res 5: 51-64.
4. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, et al. (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52: 269-324.
5. Lerner EA, Iuga AO, Reddy VB, (2007) Maxadilan, a PAC1 agonist from sand flies. Peptides 28: 1651-1654.
6. Kanekar S, Gandham M, Lucero MT, (2010) PACAP protects against TNFα-induced cell death in olfactory epithelium and olfactory placodal cell lines. Mol Cell Neurosci 45: 345-354.
7. Racz B, Horvath G, Reglodi D, Gasz B, Kiss P, et al. (2010) PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study. Regul Pept 160: 91-98.
8. Gasz B, Rácz B, Roth E, Borsiczky B, Ferencz A, et al. (2006) Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides 27: 87-94.
9. Cazillis M, Gonzalez BJ, Billardon C, Lombet A, Fraichard A, et al. (2004) VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells. Eur J Neurosci 19: 798-808.
10. Hirose M, Hashimoto H, Shintani N, Nakanishi M, Arakawa N, et al. (2005) Differential expression of mRNAs for PACAP and its receptors during neural differentiation of embryonic stem cells. Regul Pept 126: 109-113.
11. Cai J, Li W, Su H, Qin D, Yang J, et al. (2010) Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 285: 11227-11234.
12. Yu RJ, Xie QL, Dai Y, Gao Y, Zhou TH, et al. (2006) Inteinmediated rapid purification and characterization of a novel recombinant agonist for VPAC2. Peptides 27: 1359-1366.
13. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25: 402-408.
14. Pakzad M, Totonchi M, Taei A, Seifinejad A, Hassani SN, et al. (2010) Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Rev 6: 96-107.
15. Ohgushi M, Matsumura M, Eiraku M, Murakami K, Aramaki T, et al. (2010) Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7: 225-239.
16. Wang X, Lin G, Martins-Taylor K, Zeng H, Xu RH, (2009) Inhibition of caspase-mediated anoikis is critical for basic fibroblast growth factor-sustained culture of human pluripotent stem cells. J Biol Chem 284: 34054-34064.
17. Chafai M, Louiset E, Basille M, Cazillis M, Vaudry D, et al. (2006) PACAP and VIP promote initiation of electrophysiological activity in differentiating embryonic stem cells. Ann N Y Acad Sci 1070: 185-189.
18. Aino H, Hashimoto H, Ogawa N, Nishino A, Yamamoto K, et al. (1995) Structure of the gene encoding the mouse pituitary adenylate cyclaseactivating polypeptide receptor. Gene 164: 301-304.
19. Alexandre D, Vaudry H, Grumolato L, Turquier V, Fournier A, et al. (2002) Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance. Endocrinology 143: 2680-2692.
20. Morio H, Tatsuno I, Tanaka T, Uchida D, Hirai A, et al. (1996) Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neurotrophic factor for cultured rat cortical neurons. Ann N Y Acad Sci 805: 476-481.
21. Nagata S, (1997) Apoptosis by death factor. Cell 88: 355-365.
22. Kuida K, Zheng TS, Na S, Kuan C, Yang D, et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372.
23. Martin SA, Ouchi T, (2005) BRCA1 phosphorylation regulates caspase-3 activation in UV-induced apoptosis. Cancer Res 65: 10657-10662.
24. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, et al. (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12: 806-819.
25. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489.
26. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, et al. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352.
27. Earnshaw WC, Martins LM, Kaufmann SH, (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424.
28. Pirger Z, Nemeth J, Hiripi L, Toth G, Kiss P, et al. (2008) PACAP has anti-apoptotic effect in the salivary gland of an invertebrate species, Helix pomatia. J Mol Neurosci 36: 105-114.
29. Ohta S, Gregg C, Weiss S, (2006) Pituitary adenylate cyclase-activating polypeptide regulates forebrain neural stem cells and neurogenesis in vitro and in vivo. J Neurosci Res 84: 1177-1186.
30. Scharf E, May V, Braas KM, Shutz KC, Mao-Draayer Y, (2008) Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) regulate murine neural progenitor cell survival, proliferation, and differentiation. J Mol Neurosci 36: 79-88.
31. Shahhoseini M, Taei A, Mehrjardi NZ, Salekdeh GH, Baharvand H, (2010) Epigenetic analysis of human embryonic carcinoma cells during retinoic acid-induced neural differentiation. Biochem Cell Biol 88: 527-538.